Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Changes in injury incidences and causes in Swiss amateur soccer between the years 2004 and 2015.

Gebert A, Gerber M, Pühse U, Faude O, Stamm H, Lamprecht M.

Swiss Med Wkly. 2018 Dec 15;148:w14690. doi: 10.4414/smw.2018.14690. eCollection 2018 Dec 3.

2.

Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer.

Stamm H, Wellbrock J, Fiedler W.

Mamm Genome. 2018 Dec;29(11-12):694-702. doi: 10.1007/s00335-018-9770-7. Epub 2018 Aug 21. Review.

PMID:
30132062
3.

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.

Stamm H, Klingler F, Grossjohann EM, Muschhammer J, Vettorazzi E, Heuser M, Mock U, Thol F, Vohwinkel G, Latuske E, Bokemeyer C, Kischel R, Dos Santos C, Stienen S, Friedrich M, Lutteropp M, Nagorsen D, Wellbrock J, Fiedler W.

Oncogene. 2018 Sep;37(39):5269-5280. doi: 10.1038/s41388-018-0288-y. Epub 2018 May 31.

4.

Injuries in formal and informal non-professional soccer - an overview of injury context, causes, and characteristics.

Gebert A, Gerber M, Pühse U, Gassmann P, Stamm H, Lamprecht M.

Eur J Sport Sci. 2018 Sep;18(8):1168-1176. doi: 10.1080/17461391.2018.1475507. Epub 2018 May 29.

PMID:
29842824
5.

Intimate stimuli result in fronto-parietal activation changes in anorexia nervosa.

van Zutphen L, Maier S, Siep N, Jacob GA, Tüscher O, van Elst LT, Zeeck A, Arntz A, O'Connor MF, Stamm H, Hudek M, Joos A.

Eat Weight Disord. 2018 Feb 3. doi: 10.1007/s40519-017-0474-x. [Epub ahead of print]

PMID:
29397562
6.

Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia.

Latuske EM, Stamm H, Klokow M, Vohwinkel G, Muschhammer J, Bokemeyer C, Jücker M, Kebenko M, Fiedler W, Wellbrock J.

Oncotarget. 2017 Apr 25;8(17):29187-29201. doi: 10.18632/oncotarget.16304.

7.

TRAITEMENT OESTROGÉNIQUE DE L'INCONTINENCE URINAIRE.

Stamm H.

Rev Med Suisse. 2016 Feb 24;12(507):417. French. No abstract available.

PMID:
27039609
8.

Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.

Degwert N, Latuske E, Vohwinkel G, Stamm H, Klokow M, Bokemeyer C, Fiedler W, Wellbrock J.

Eur J Haematol. 2016 Sep;97(3):239-44. doi: 10.1111/ejh.12711. Epub 2015 Dec 28.

PMID:
26613208
9.

Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells.

Werner S, Stamm H, Pandjaitan M, Kemming D, Brors B, Pantel K, Wikman H.

BMC Cancer. 2015 Nov 11;15:896. doi: 10.1186/s12885-015-1907-4.

10.

Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension.

Wellbrock J, Harbaum L, Stamm H, Hennigs JK, Schulz B, Klose H, Bokemeyer C, Fiedler W, Lüneburg N.

Lung. 2015 Aug;193(4):567-70. doi: 10.1007/s00408-015-9735-5. Epub 2015 Apr 30.

PMID:
25926293
11.

Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.

Wellbrock J, Latuske E, Köhler J, Wagner K, Stamm H, Vettorazzi E, Vohwinkel G, Klokow M, Uibeleisen R, Ehm P, Riecken K, Loges S, Thol F, Schubert C, Amling M, Jücker M, Bokemeyer C, Heuser M, Krauter J, Fiedler W.

Clin Cancer Res. 2015 May 15;21(10):2388-98. doi: 10.1158/1078-0432.CCR-14-1059. Epub 2015 Mar 5.

12.

Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: implications on pathophysiology and early disease detection.

Wellbrock J, Sheikhzadeh S, Oliveira-Ferrer L, Stamm H, Hillebrand M, Keyser B, Klokow M, Vohwinkel G, Bonk V, Otto B, Streichert T, Balabanov S, Hagel C, Rybczynski M, Bentzien F, Bokemeyer C, von Kodolitsch Y, Fiedler W.

PLoS One. 2014 Aug 12;9(8):e104742. doi: 10.1371/journal.pone.0104742. eCollection 2014.

13.

Excess weight among children and adolescents in Switzerland--prevalence and correlates for the early 2010s.

Stamm H, Gebert A, Guggenbühl L, Lamprecht M.

Swiss Med Wkly. 2014 May 20;144:w13956. doi: 10.4414/smw.2014.13956. eCollection 2014.

14.

The European Commission's recommendation on the definition of nanomaterial makes an impact.

Rauscher H, Sokull-Klüttgen B, Stamm H.

Nanotoxicology. 2013 Nov;7(7):1195-7. doi: 10.3109/17435390.2012.724724. Epub 2012 Sep 17. No abstract available.

PMID:
22920756
15.

Detection of nanomaterials in food and consumer products: bridging the gap from legislation to enforcement.

Stamm H, Gibson N, Anklam E.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012 Aug;29(8):1175-82. doi: 10.1080/19440049.2012.689778. Epub 2012 Jun 22.

PMID:
22725966
16.

Approaches to the safety assessment of engineered nanomaterials (ENM) in food.

Cockburn A, Bradford R, Buck N, Constable A, Edwards G, Haber B, Hepburn P, Howlett J, Kampers F, Klein C, Radomski M, Stamm H, Wijnhoven S, Wildemann T.

Food Chem Toxicol. 2012 Jun;50(6):2224-42. doi: 10.1016/j.fct.2011.12.029. Epub 2011 Dec 29. Review.

PMID:
22245376
17.

Risk factors: Nanomaterials should be defined.

Stamm H.

Nature. 2011 Aug 24;476(7361):399. doi: 10.1038/476399c. No abstract available.

PMID:
21866144
18.

FLOW (finding lasting options for women): multicentre randomized controlled trial comparing tampons with menstrual cups.

Howard C, Rose CL, Trouton K, Stamm H, Marentette D, Kirkpatrick N, Karalic S, Fernandez R, Paget J.

Can Fam Physician. 2011 Jun;57(6):e208-15.

19.

Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators.

Gibson N, Holzwarth U, Abbas K, Simonelli F, Kozempel J, Cydzik I, Cotogno G, Bulgheroni A, Gilliland D, Ponti J, Franchini F, Marmorato P, Stamm H, Kreyling W, Wenk A, Semmler-Behnke M, Buono S, Maciocco L, Burgio N.

Arch Toxicol. 2011 Jul;85(7):751-73. doi: 10.1007/s00204-011-0701-6. Epub 2011 Apr 11. Review.

PMID:
21479952
20.

Countrywide campaign to prevent soccer injuries in Swiss amateur players.

Junge A, Lamprecht M, Stamm H, Hasler H, Bizzini M, Tschopp M, Reuter H, Wyss H, Chilvers C, Dvorak J.

Am J Sports Med. 2011 Jan;39(1):57-63. doi: 10.1177/0363546510377424. Epub 2010 Oct 17.

PMID:
20956263
21.

Allez Hop, a nationwide programme for the promotion of physical activity in Switzerland: what is the evidence for a population impact after one decade of implementation?

Wanner M, Martin-Diener E, Bauer GF, Stamm H, Martin BW.

Br J Sports Med. 2011 Dec;45(15):1202-7. doi: 10.1136/bjsm.2009.070201. Epub 2010 Jun 11.

22.

Free breathing cardiac real-time cine MR without ECG triggering.

Beer M, Stamm H, Machann W, Weng A, Goltz JP, Breunig F, Weidemann F, Hahn D, Köstler H.

Int J Cardiol. 2010 Nov 19;145(2):380-382. doi: 10.1016/j.ijcard.2010.02.052. Epub 2010 Mar 11.

PMID:
20223537
23.

The public perception of doping in sport in Switzerland, 1995-2004.

Stamm H, Lamprecht M, Kamber M, Marti B, Mahler N.

J Sports Sci. 2008 Feb 1;26(3):235-42.

PMID:
18074297
24.

Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine.

Larbig M, Burtin B, Martin L, Stamm H, Luettig B, Hohlfeld JM, Krug N.

Br J Clin Pharmacol. 2006 Aug;62(2):158-64.

25.

Physical activity of adults aged 50 years and older in Switzerland.

Meyer K, Rezny L, Breuer C, Lamprecht M, Stamm HP.

Soz Praventivmed. 2005;50(4):218-29.

PMID:
16167506
26.

Performance assessment of photon migration instruments: the MEDPHOT protocol.

Pifferi A, Torricelli A, Bassi A, Taroni P, Cubeddu R, Wabnitz H, Grosenick D, Möller M, Macdonald R, Swartling J, Svensson T, Andersson-Engels S, van Veen RL, Sterenborg HJ, Tualle JM, Nghiem HL, Avrillier S, Whelan M, Stamm H.

Appl Opt. 2005 Apr 10;44(11):2104-14.

PMID:
15838951
27.

The terror part of terrorism.

Stamm BH, Tuma F, Norris FH, Piland NF, van der Hart O, Fairbank JA, Stamm HE 4th, Higson-Smith C, Barbanel L, Levant RF.

IEEE Eng Med Biol Mag. 2004 Jan-Feb;23(1):149-61. No abstract available.

PMID:
15154272
28.

"Getting Switzerland to move": evaluation of a new "Sport for All" programme.

Stamm H, Lamprecht M, Somaini B, Peters M.

Soz Praventivmed. 2001;46(1):20-8.

PMID:
11320910
29.

[Pregnancy interruption in Switzerland 1942-1996].

Dondénaz M, Gutzwiller F, Rey AM, Stamm H.

Praxis (Bern 1994). 1997 Feb 25;86(9):340-7. German.

PMID:
9157503
30.

Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance program.

Eckardt VF, Stamm H, Kanzler G, Bernhard G.

Endoscopy. 1994 Aug;26(6):523-7.

PMID:
7828564
31.

[Gestational diabetes].

Marini M, Chabot VA, Stamm H, Berger W.

Schweiz Med Wochenschr Suppl. 1994;60:47-52. French, German. No abstract available.

PMID:
8016613
32.

[Interruption of pregnancy in Switzerland 1982-1986].

Stamm H, Gloor PA, Dondénaz M, Hagmann HM, Hurni M, Stucki D.

Schweiz Rundsch Med Prax. 1990 Feb 27;79(9):229-34. German.

PMID:
2333449
33.

Predictive value of EGF receptor in breast cancer.

Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U.

Lancet. 1988 Nov 26;2(8622):1258. No abstract available.

PMID:
2903994
35.

[Guidelines of the Swiss Diabetic Association on diabetes and contraception].

Chabot V, Berger W, Stamm H.

Schweiz Rundsch Med Prax. 1986 May 20;75(21):629-31. French. No abstract available.

PMID:
3726362
36.

[Guidelines of the Swiss Diabetic Association concerning pregnancy in diabetes].

Chabot V, Berger W, Bossi E, Stamm H.

Schweiz Rundsch Med Prax. 1986 May 20;75(21):632-4. French. No abstract available.

PMID:
3523676
37.

Rabbit oviduct mucosa healing after accidental transmucosal suture passage.

Vuillemin M, Pexieder T, Janecek P, Stamm H.

Microsurgery. 1986;7(3):138-45.

PMID:
3022103
38.

[Pregnancy termination in Switzerland. Development 1979-1981].

Gloor PA, Hagmann HM, Hurni M, Stamm H, Stucki D.

Schweiz Rundsch Med Prax. 1985 Apr 23;74(17):434-8. German. No abstract available.

PMID:
4001684
39.

The prevention of postoperative venous thrombosis.

Stamm H.

Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S19-22.

PMID:
2432022
40.

[Vasectomy within the scope of contraception].

Stamm H, Acheampong A.

Gynakol Rundsch. 1984;24(2):85-97. German. No abstract available.

PMID:
6610606
41.

[50 years' medical research in Waldenburg].

Stamm H.

Gesnerus. 1983;40(3-4):281-90. German. No abstract available.

PMID:
6360800
42.

[Legal abortion in Switzerland; some numbers and evolution (author's transl)].

Gloor PA, Hagmann HM, Hurni M, Stamm H, Stucki D.

Schweiz Rundsch Med Prax. 1982 Feb 9;71(6):225-9. French. No abstract available.

PMID:
7063440
43.

[Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].

Stamm H, De Grandi P.

Rev Med Suisse Romande. 1981 Nov;101(11):913-7. French.

PMID:
7323568
44.

[Gynecologic-obstetrical emergencies].

Stamm H.

Ther Ggw. 1981 Mar;120(3):253-64. German. No abstract available.

PMID:
7221957
45.
46.

[The development of obstetrics in Basel].

Stamm H.

Gesnerus. 1981;38(1-2):23-50. German. No abstract available.

PMID:
7014381
47.

[Risks in legal, induced abortion. Review of the literature].

Stamm HE.

Gynakol Rundsch. 1980;20(2):65-84. German.

PMID:
7192247
48.

[The cost of the termination of pregnancy. Delayed medical complications. A Lausanne study].

Stamm HE, Revaz C.

Rev Med Suisse Romande. 1979 Dec;99(12):885-8. French. No abstract available.

PMID:
547336
49.

[The cost of the termination of pregnancy. Medical aspects].

Revaz C, Stamm HE.

Rev Med Suisse Romande. 1979 Dec;99(12):873-83. French. No abstract available.

PMID:
547335
50.

[Results of restorative surgery in unbroken extrauterine pregnancies].

Janecek P, Welti HJ, Stamm HE.

Rev Med Suisse Romande. 1979 Sep;99(9):603-10. French. No abstract available.

PMID:
538376

Supplemental Content

Support Center